Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AURKA | O14965 | 1/20 | 0.64 |
| ▸ | AURKB | Q96GD4 | 1/20 | 0.64 |
| ▸ | LRRK2 | Q5S007 | 2/20 | 0.63 |
| ▸ | BRD4 | O60885 | 9/20 | 0.61 |
| ▸ | DCLK1 | O15075 | 1/20 | 0.61 |
| ▸ | MAPK7 | Q13164 | 1/20 | 0.61 |
| ▸ | PLK1 | P53350 | 9/20 | 0.60 |
| ▸ | BRDT | Q58F21 | 5/20 | 0.60 |
| ▸ | PTK2 | Q05397 | 5/20 | 0.60 |
| ▸ | IGF1R | P08069 | 1/20 | 0.59 |
| ▸ | RAD52 | P43351 | 1/20 | 0.59 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4239425 | 0.93 | PTK2 (0.62) | AURKAAURKBLRRK2BRD4DCLK1 | |
| SCHEMBL4231902 | 0.92 | PTK2 (0.67) | AURKAAURKBBRD4DCLK1MAPK7 | |
| SCHEMBL4233250 | 0.91 | RAD52 (0.62) | AURKAAURKBLRRK2BRD4DCLK1 | |
| SCHEMBL4245454 | 0.91 | PTK2 (0.68) | AURKAAURKBBRD4DCLK1MAPK7 | |
| SCHEMBL4234353 | 0.88 | PTK2 (0.69) | AURKAAURKBLRRK2BRD4DCLK1 | |
| SCHEMBL4228054 | 0.88 | PTK2 (0.57) | AURKAAURKBLRRK2BRD4DCLK1 | |
| SCHEMBL4240691 | 0.85 | BRD4 (0.64) | AURKAAURKBLRRK2BRD4DCLK1 | |
| SCHEMBL4242620 | 0.84 | AURKA (0.59) | AURKAAURKBLRRK2BRD4DCLK1 | |
| SCHEMBL5921305 | 0.84 | PLK1 (0.64) | AURKAAURKBBRD4DCLK1MAPK7 | |
| SCHEMBL4234396 | 0.83 | BRD4 (0.59) | AURKAAURKBLRRK2BRD4DCLK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2100894-A1 | Pyridopyrimidines used as Plk1 (polo-like kinase) inhibitors | 4SC AG (DE) | 2009-09-16 | — | — | EP | disclosed |